Time：2024-07-12
Chinese Peptide Company, a Medtide Inc. subsidiary, recently secured GMP certificates from Australia's Therapeutic Goods Administration (TGA) for three API products. Given Australia's stringent drug manufacturing and import regulations, TGA certification is globally recognized for its rigorous standards. The successful first-time certification of all three products demonstrates TGA's strong confidence in Chinese Peptide quality management systems, production facilities, and operational standards.
About TGA
The Therapeutic Goods Administration (TGA) is Australia's government authority that regulates all therapeutic products, including pharmaceuticals, medical devices, and in vitro diagnostic reagents.
Under the Therapeutic Goods Act 1989, all therapeutic goods (medicines and medical devices) sold in Australia must be registered or listed with the TGA. Products can only be legally marketed after securing registration on the Australian Register of Therapeutic Goods (ARTG).
